The association of in-utero exposure to polycyclic aromatic hydrocarbons and umbilical liver enzymes

The adverse health influences of polycyclic aromatic hydrocarbons (PAHs) exposures have been examined in several previous research. However, the evidence on the health influences of PAHs exposure during pregnancy and childhood is scarce, with no study on the infant's liver function. Therefore,...

Full description

Saved in:
Bibliographic Details
Published in:The Science of the total environment Vol. 889; p. 164220
Main Authors: Wanying, Li, Okromelidze, Mariami T., Ramírez-Coronel, Andrés Alexis, Zekiy, Angelina O., Obaid, Rasha Fadhel, Jawhar, Zanko Hassan, Gabr, Gamal A., Al-Hamdani, Mais Mazin, Kadhim, Sokaina Issa, Mustafa, Yasser Fakri, Najafi, Moslem Lari, Miri, Mohammad
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-09-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The adverse health influences of polycyclic aromatic hydrocarbons (PAHs) exposures have been examined in several previous research. However, the evidence on the health influences of PAHs exposure during pregnancy and childhood is scarce, with no study on the infant's liver function. Therefore, in this study, the association of in-utero exposure to particulate matter-bound PAHs (PM-bound PAHs) on the umbilical liver enzymes was investigated. A total of 450 mother-pair samples were assessed in this cross-sectional study in Sabzevar, Iran (2019–2021). The concentrations of PM-bound PAHs were estimated based on spatiotemporal models at residential addresses. The umbilical cord blood alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) were measured as indicators of infant's liver function. The association of PM-bound PAHs with umbilical liver enzymes was evaluated using multiple linear regression, controlled for relevant covariates. The quantile g-computation (g-comp) was used to investigate the combined impact of the 15 PAHs on liver function biomarkers. Higher levels of total 4-ring PAHs, Dibenzo[a,h]anthrancene, Anthracene, Pyrene, Benzo[a]anthracene, Phenanthrene, Fluorene, Acenaphthylene and Naphthalene were associated with higher umbilical ALP. An increase in total 5-ring PAHs, Benzo[g,h,i]perylene, Benzo[a]pyrene and Chrysene was associated with higher umbilical AST levels. Each 1 ng/m3 increase in exposure to Benzo[g,h,i]perylene was related with 182.21 U/L (95 % CI: 116.11, 248.31, P < 0.01) increase in umbilical GGT. PAHs mixture exposure was positively associated with higher umbilical AST and ALT, while no significant associations were noted for ALP and GGT. We observed a potentially stronger association for girls compared to boys based on umbilical ALT and AST. However, for GGT and ALP, these associations were stronger for boys compared to girls. Overall our findings suggested that exposure to PAHs during pregnancy had adverse effects on infant's liver function. [Display omitted] •Maternal exposure to PM-bound PAHs and fetal liver function were assessed.•Higher levels of PAHs were associated with higher umbilical AST levels.•Higher Benzo[g,h,i]perylene was associated with an increase in umbilical GGT level.•The associations of exposure to PAHs and ALT were not statistically significant.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0048-9697
1879-1026
DOI:10.1016/j.scitotenv.2023.164220